Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

DNA (Cytosine-5-)-Methyltransferase 3 beta (DNMT3B) (Middle Region) Peptide

DNMT3B Hôte: Synthetic BP, WB
N° du produit ABIN8099039
168,15 €
Plus frais de livraison 40,00 € et TVA
100 μg
Destination: France
Envoi sous 6 à 9 jours ouvrables

Aperçu rapide pour DNA (Cytosine-5-)-Methyltransferase 3 beta (DNMT3B) (Middle Region) Peptide (ABIN8099039)

Antigène

DNMT3B (DNA (Cytosine-5-)-Methyltransferase 3 beta (DNMT3B))

Source

  • 3
Synthetic

Application

Blocking Peptide (BP), Western Blotting (WB)
  • Protein Region

    Middle Region

    Fonction

    DNMT3B Peptide - middle region
  • Indications d'application

    Optimal working dilution should be determined by the investigator.

    Commentaires

    This is a synthetic peptide designed for use in combination with anti-DNMT3B antibody ( ARP49124_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

    Buffer

    Lyophilized powder

    Stock

    -20 °C

    Stockage commentaire

    For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
  • Antigène

    DNMT3B (DNA (Cytosine-5-)-Methyltransferase 3 beta (DNMT3B))

    Sujet

    Background Information: DNMT3B is required for genome wide de novo methylation and is essential for the establishment of DNA methylation patterns during development. DNA methylation is coordinated with methylation of histones. DNMT3B may preferentially methylate nucleosomal DNA within the nucleosome core region. DNMT3B may function as transcriptional co-repressor by associating with CBX4 and independently of DNA methylation. DNMT3B seems to be involved in gene silencing. In association with DNMT1 and via the recruitment of CTCFL/BORIS, DNMT3B is involved in activation of BAG1 gene expression by modulating dimethylation of promoter histone H3 at H3K4 and H3K9. CpG methylation is an epigenetic modification that is important for embryonic development, imprinting, and X-chromosome inactivation. Studies in mice have demonstrated that DNA methylation is required for mammalian development. This gene encodes a DNA methyltransferase which is thought to function in de novo methylation, rather than maintenance methylation. The protein localizes primarily to the nucleus and its expression is developmentally regulated. Mutations in this gene cause the immunodeficiency-centromeric instability-facial anomalies (ICF) syndrome. Six alternatively spliced transcript variants have been described. The full length sequences of variants 4 and 5 have not been determined.

    Alternative Symbols: ICF, M.HsaIIIB, ICF1

    Poids moléculaire

    86kDa

    ID gène

    1789

    NCBI Accession

    NP_787045

    UniProt

    Q9UBC3
Vous êtes ici:
Chat with us!